Skip to content


We are pleased to present an exciting 4-part webinar series on personalized medicine – from basic research to post-marketing activities. 

Tune in to learn more about personal medicine in Denmark

Each episode will provide an overview of the Danish research infrastructure within a specific phase of the drug development process and an opportunity for virtual meetings with leading Danish researchers and physicians as well as key officials from public health data organizations, including biobanks, health data, clinical and technology research.

Attending the webinar series will provide a direct pathway to access the unique framework that Denmark offers for pharmaceutical companies for the research, development, and clinical use of personalized medicine. 

Why Personalized medicine in Denmark?

  • Denmark has a national strategy for personalized medicine.

  • A recent study shows that Denmark has the most supportive environment for personalized medicine in Europe.

  • Denmark offers unique possibilities of realizing the potential of personalized medicine, e.g. due to a health data goldmine with more than 170 national registers plus a vast number of biobanks.

  • Denmark offers excellent framework conditions for health research.

  • Denmark offers efficient public authorities with fast and service-oriented case handling.

Background info

The series will be free of charge and hosted by Invest in Denmark, a part of The Danish Ministry of Foreign Affairs, and the Danish Association of the Pharmaceutical Industry.
The webinar series on personalized medicine origins from a physical seminar on personalized medicine, which was scheduled to take place in spring 2020. Due to the COVID-19 pandemic, the seminar was cancelled.

get in touch Want to know more about personalized medicine in Denmark?

Please contact our dedicated life science experts here: